Azatadin: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
←Membuat halaman berisi '{{Drugbox | verifiedrevid = 477164914 | IUPAC_name = 11-(1-Methylpiperidin-4-ylidene)-6,11-dihydro-5''H''-benzo[5,6]cyclohepta[1,2-''b'']pyridine | image = Azatadine.svg <!--Clinical data--> | tradename = Optimine | Drugs.com = {{drugs.com|CONS|azatadine}} | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = B | legal_AU = <!-- Unscheduled / S2 / S4 / S8 --> | legal_UK = <!-- GSL / P / POM / CD --> | legal_US = <!--Identifiers--> | IUPHAR_liga...' Tag: kemungkinan perlu dirapikan Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
Baris 1:
{{Drugbox
| verifiedrevid = 477164914
| IUPAC_name = 11-(1-
| image = Azatadine.svg
<!--Clinical data-->
Baris 39:
}}
'''
Obat ini dipatenkan pada tahun 1967.<ref>{{cite patent | title = Azatadine | inventor = Villani FJ, Caldwell W | country = US | number = 3326924 | gdate = 1967 }}</ref> Obat ini telah digantikan oleh [[loratadin]] dan [[desloratadin]].<ref>{{cite book | vauthors = Horak F | chapter = Antialergic and Vasoactive Drugs for Allergic Rhinitis. Chapter 4 | title = Allergy Frontiers:Therapy and Prevention. | volume = 5 | veditors = Pawankar R, Holgate ST, Rosenwasser LJ | publisher = Springer Science & Business Media | date = 2010 | isbn = 9784431993629 }}</ref>{{rp|53}} dan persetujuan pemasarannya telah banyak ditarik.<ref>{{cite web | work = Drugs.com | url = https://www.drugs.com/mtm/azatadine.html | title = Azatadine }}</ref><ref>{{cite web | work = Federal Register 70 FR 10651 | date = 2005 | url = https://www.federalregister.gov/articles/2005/03/04/05-4158/hospira-inc-et-al-withdrawal-of-approval-of-76-new-drug-applications-and-60-abbreviated-new-drug | author = Food and Drug Administration | title = Docket No.2005N-0058: Hospira, Inc. et al.; Withdrawal of Approval of 76 New Drug Applications and 60 Abbreviated New Drug Applications }} </ref><ref>{{cite web | work = Federal Register 72 FR 8184 | date = 2007 | url = http://www.gpo.gov/fdsys/pkg/FR-2007-02-23/html/E7-3043.htm | author = Food and Drug Administration | title = Docket No. 2004P-0262: Withdrawal of Approval of 128 Suitability Petitions }}</ref><ref>{{cite web | work = Department of Economic and Social Affairs of the United Nations Secretariat | url = https://www.un.org/esa/coordination/CL12.pdf | title = Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments Twelfth Issue: Pharmaceuticals | publisher = United Nations | location = New York | date = 2005 }}</ref>{{rp|290}}<ref>{{cite web | work = FDA | url = https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ucm283497.htm | title = OGD Suitability Tracking Report (Sorted by Drug Name) }}</ref>
== Referensi ==
{{Reflist}}
| |||